We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+13.8%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$2.61B
AUM Growth
+$292M
Cap. Flow
+$4.3M
Cap. Flow %
0.16%
Top 10 Hldgs %
19.76%
Holding
1,079
New
101
Increased
398
Reduced
436
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Healthcare 10.65%
3 Financials 10.27%
4 Consumer Staples 8.1%
5 Industrials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAL icon
301
Halliburton
HAL
$26.6B
$1.27M 0.05%
67,422
+5,671
+9% +$88K
LVS icon
302
Las Vegas Sands
LVS
$30.3B
$1.27M 0.05%
21,349
-573
-3% -$30.6K
CTVA icon
303
Corteva
CTVA
$53.2B
$1.27M 0.05%
32,754
-1,343
-4% -$48K
WMB icon
304
Williams Companies
WMB
$87.8B
$1.24M 0.05%
62,069
+7,200
+13% +$146K
NEA icon
305
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
$1.24M 0.05%
82,016
+3,525
+4% +$51.4K
AZN icon
306
AstraZeneca
AZN
$252B
$1.24M 0.05%
12,374
-2,242
-15% -$237K
NVO
307
Novo Nordisk
NVO
$200B
$1.23M 0.05%
35,166
-3,120
-8% -$108K
CWB icon
308
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.74B
$1.23M 0.05%
14,796
+4,610
+45% +$348K
SPGI icon
309
S&P Global
SPGI
$121B
$1.22M 0.05%
3,710
-1,155
-24% -$390K
ED icon
310
Consolidated Edison
ED
$39.6B
$1.22M 0.05%
16,816
-211
-1% -$16.4K
OXY icon
311
Occidental Petroleum
OXY
$53.8B
$1.21M 0.05%
70,072
-15,486
-18% -$212K
CMI icon
312
Cummins
CMI
$90.9B
$1.21M 0.05%
5,322
+263
+5% +$59.1K
GOVT icon
313
iShares US Treasury Bond ETF
GOVT
$43.6B
$1.2M 0.05%
43,868
-829
-2% -$22.9K
XLY icon
314
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
$1.19M 0.05%
14,822
+4,144
+39% +$319K
FV icon
315
First Trust Dorsey Wright Focus 5 ETF
FV
$3.74B
$1.19M 0.05%
29,385
-582
-2% -$21.8K
TDG icon
316
TransDigm Group
TDG
$69.5B
$1.19M 0.05%
1,923
+210
+12% +$115K
GWRE icon
317
Guidewire Software
GWRE
$13.2B
$1.19M 0.05%
9,217
+143
+2% +$16.3K
VOT icon
318
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
$1.18M 0.05%
5,576
+357
+7% +$70.3K
ELV icon
319
Elevance Health
ELV
$84.3B
$1.17M 0.04%
3,634
-328
-8% -$101K
IJK icon
320
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
$1.17M 0.04%
16,136
-956
-6% -$63.7K
CHNG
321
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$1.16M 0.04%
62,169
-4,802
-7% -$78.9K
MKC icon
322
McCormick & Company Non-Voting
MKC
$14B
$1.16M 0.04%
12,078
+400
+3% +$37.8K
IVE icon
323
iShares S&P 500 Value ETF
IVE
$49.7B
$1.15M 0.04%
8,964
+127
+1% +$15.4K
SRCL
324
DELISTED
Stericycle Inc
SRCL
$1.14M 0.04%
16,432
-1,425
-8% -$97.5K
NGG icon
325
National Grid
NGG
$80.7B
$1.14M 0.04%
21,733
-76
-0.3% -$4.03K

Similar funds

Raymond James Trust's Q4 2020 Portfolio in Review

As of Q4 2020, Raymond James Trust held 1,079 positions worth $2.61B, up 13% from $2.32B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James Trust's Q4 2020 filing shows 101 new, 398 increased, 436 reduced and 41 closed positions. Its largest new stake was Invesco S&P 500 Pure Value ETF: 22,191 shares worth $1.36M. The largest sale was Fulgent Genetics, an estimated $37.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James Trust's largest Q4 2020 buy was Invesco S&P 500 Pure Value ETF: 22,191 shares worth $1.36M.
  • Raymond James Trust added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $6.25M increase.
  • Raymond James Trust's biggest Q4 2020 reduction was Fulgent Genetics, cutting an estimated $37.7M.
  • Raymond James Trust fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $981K.
  • Raymond James Trust's ten largest holdings make up 20% of its $2.61B portfolio in Q4 2020.
  • Raymond James Trust opened 101 new positions and closed 41 in Q4 2020.
  • Raymond James Trust's portfolio value rose 13% quarter-over-quarter to $2.61B.

Based on Raymond James Trust's 13F filing for Q4 2020, filed 13 Jan 2021.